PRELUDE CAPITAL MANAGEMENT, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2020$77,000
-73.8%
32,308
-31.8%
0.00%
-76.5%
Q3 2018$294,000
+10.5%
47,400
-19.5%
0.02%0.0%
Q2 2018$266,000
+0.8%
58,879
+2.8%
0.02%
-10.5%
Q1 2018$264,000
+94.1%
57,300
+35.2%
0.02%
+72.7%
Q4 2017$136,000
+13.3%
42,376
+8.7%
0.01%0.0%
Q3 2017$120,000
-7.7%
39,000
+11.0%
0.01%
-8.3%
Q2 2017$130,000
-18.8%
35,147
+7.5%
0.01%
-20.0%
Q1 2017$160,000
+3.9%
32,696
+9.0%
0.02%
-21.1%
Q4 2016$154,000
-19.4%
30,000
+13.9%
0.02%
-5.0%
Q3 2016$191,000
+76.9%
26,329
+45.5%
0.02%
+33.3%
Q2 2016$108,000
+0.9%
18,100
+37.2%
0.02%0.0%
Q1 2016$107,000
+10.3%
13,195
+10.0%
0.02%0.0%
Q4 2015$97,000
+5.4%
12,000
+9.1%
0.02%
+15.4%
Q3 2015$92,000
+17.9%
11,000
+31.0%
0.01%
+18.2%
Q2 2015$78,000
+680.0%
8,400
+740.0%
0.01%
+1000.0%
Q1 2015$10,000
-44.4%
1,000
-37.5%
0.00%
-66.7%
Q4 2014$18,0001,6000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders